College Stock: Penny Stock News

It’s official, The Dean is going Hollywood! The news release below outlines the production agreement between Wide World of Stocks and NBC (plus ION TV) to air the first ever Micro Cap Television Show to +100 million households. The Wide World of Stocks TV Show debuts on Wednesday, July 8th at 12:00pm EDT (directly after Martha Stewart Living).

The Dean is one of 3 co-anchors on the Wide World of Stocks and during the first episode he teaches a global audience all about the biotechnology sector, how to spot new trends and why he believes Viral Genetics (VRAL) is one of the greatest opportunities of our lifetime because of the VGV-1 injectable drug.

Tune in July 8th @ 12pm EDT to find out what The Dean has to say about VRAL!

The Dean Is Coming Soon To A Television Near You!

PORT JEFFERSON, N.Y.–(BUSINESS WIRE)–Wide World of Stocks, a new 30-minute pre-recorded television and website program that features microcap companies, has secured agreements with WNBC Channel 4 in New York and ION Television Network. As a result, the program is expected to reach more than 100 million households nationwide. The program’s producers aspire to scour the globe in search of microcap equities with the potential to become the next big market mover. The show will debut Wednesday, July 8, at noon, on NBC directly after Martha Stewart Living. The first episode will feature Viral Genetics’ (VRAL) CEO, Mr. Haig Keledjian. Viral Genetics is developing drug therapies for HIV/AIDS, Lyme Disease, and other autoimmune diseases.

Additional WNBC broadcasts are scheduled for noon on Sunday, July 12^th and Sunday, July 19^th, just after The Wall Street Journal Report. The current broadcast schedule is still evolving as producers for Wide World of Stocks make additional media buys. As agreements are developed with more networks, the schedule will be updated and posted online at www.wideworldofstocks.com, where episodes of the program will be available for viewing after the fist WNBC broadcast.

Viral Genetics was chosen for the first episode of Wide World of Stocks. The company’s drug compound called VGV-1, has already undergone five clinical trials overseas, where it was found to reduce the viral load and symptoms of HIV/AIDS. Due to its novel mechanism, low toxicity profile, simple dosing regimen, and short course of treatment, researches at the company believe its therapy called “thymus nuclear protein,” (TNP) is extremely promising for other applications as well. Details about regarding the status of Viral Genetics’ drug compound and TNP therapy are available at www.viralgenetics.com.

Wide World of Stocks will be hosted by Damon Roberts with co-hosts Roland Rick Perry and Thomas McCarthy, “The Dean” of CollegeStock.com. Each of the hosts manages their own websites that combined reach more than 550,000 subscribers.

Remember that Honors Students are the first in line to receive all of The Dean’s most valuable information. When trading penny stocks, knowledge is power and it only costs $9.87/month with The Dean’s Barely Legal Inside Information for just $9.87/month. To stay up to date on all of The Dean’s latest penny stock picks and TV commentary be sure to sign up now because you’re either in, or you’re out.